Verification register Bio, Health & Neuro
Living definition
What is Unity Biotechnology UBX1325 (foselutoclax) senolytic?
Longevity & Aging Biotech Bio, Health & Neuro
- As of
- 2026-08-20
- Revision
- 2026-08-17.1
- Method
- v1.3.0
Definition
The term, in context
AI-assisted draft · approved dataset
Unity Biotechnology UBX1325, also called foselutoclax, is a senolytic drug candidate designed to selectively clear aged, dysfunctional cells from tissue such as the eye.
Live readiness status
Status as of the current dateline
AI-assisted assembly · derived results
As of 2026-08-20, verified readiness is 5 (claimed 35, reported 17, gap 30) — Weak evidence strength; current signals suggest Do not rely on; treat as orphaned asset.
The readiness fact belongs to the canonical Readiness Verdict for Unity Biotechnology UBX1325 (foselutoclax) senolytic.
Dataset approval
Human editorial release
pragma.vision editorial — standing authorization (operator dev@soft.house, 2026-07-17)
- Dataset
- 2026-08-17.1
- Hash
- sha256:0c37108a182f510fc8cf4d1dfc3a30339f2b59e62654201edea2f530a268707e
- Approved
- 2026-08-17